International Clinical Trial: A Single-Arm, Open-Label, Single-Center Study to Evaluate the Safety and Efficacy of PX Protease in the Tr eatment of Pseudomyxoma Peritonei (PMP)

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128859) titled 'A Single-Arm, Open-Label, Single-Center Study to Evaluate the Safety and Efficacy of PX Protease in the Tr eatment of Pseudomyxoma Peritonei (PMP)' on July 27.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Cancer Hospital Chinese Academy of Medical Sciences

Condition: Pseudomyxoma Peritonei (PMP)

Intervention: Safety Run-In Period, First 3 Subjects:intratumoral injection

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-12-19

Target Sample Size: Safety Run-In Period, First 3 Subjects:3;For Subsequently Enrolled Subjects:7;

Countries of Recruitment...